慢性阻塞性肺病和呼吸道微生物组:临床医生的一篇评论
Lingxin Luo1, Junli Tang1, Xianzhi Du1
1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, PR China.
呼吸道微生物群影响慢性阻塞性肺病 (COPD) 的进展和恶化. 了解这种关系为COPD病原和潜在的微生物组向治疗提供了新的见解.
科学领域:
- 肺部医学 肺部医学
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种进展性呼吸道疾病,具有显著的发病率和死亡率.
- 呼吸道炎症和空气流量限制是COPD的标志.
- 人们越来越认识到呼吸道微生物组在COPD病原发生中的作用.
研究的目的:
- 审查呼吸道微生物组与COPD之间的复杂关系.
- 探索这种相互作用背后的潜在机制.
- 讨论COPD的基于微生物的治疗策略.
主要方法:
- 对调查COPD呼吸道微生物组的研究进行文献综述.
- 分析微生物组组成与COPD阶段,炎症和治疗反应之间的相关性.
- 检查拟议的病理生理机制,将微生物组与COPD联系起来.
主要成果:
- 呼吸道微生物组组成与COPD进展,炎症内型和对葡萄皮质类药物和抗生素的反应有关.
- 机制包括"恶性循环"假设,宿主免疫失调,以及COPD中的微生物"自然选择".
- 呼吸道微生物组显示了COPD进展,恶化和预后的预测价值.
结论:
- 呼吸道微生物组是COPD病原和进展的关键因素.
- 针对呼吸道微生物组为新型COPD治疗提供了一个有希望的途径.
- 微生物组分析可以指导临床管理,并预测COPD患者的结果.
更多相关视频
07:38Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
